Clinical Trials

Evidence of Haloperidol Absorption After Topical Administration

Location:

Scottsdale and Phoenix,  AZ

Trial status:

Open for Enrollment

Why is this study being done?

This will be a blinded study to compare the absorption of topical haloperidol with placebo

Who is eligible to participate?

Inclusion Criteria

- Age: patient must be 18 years or older and less than 70 years of age.

- Provision of informed consent

- No previous adverse reaction to haloperidol

- No current use of haloperidol

- Good health

- No alcohol within 24 hours of the study

- No significant cardiovascular, gastrointestinal, hematologic, neurologic, renal, hepatic or pulmonary disease.

- Normal neurologic exam

Exclusionary Criteria

- Evidence of any other significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the study

- Recent cerebral trauma

- Study will exclude women who are pregnant and/or nursing

- Women who are of child bearing potential must have a negative urine pregnancy test.

- History of seizures

- Taking medications that can interact with haloperidol

- Subjects with significant cardiovascular (cardiac conduction deficits), gastrointestinal, hematologic, neurologic, renal, hepatic or pulmonary disease.

Last updated: 04/01/2013

NCT ID:

NCT01684969